June 17, 2024 • 2hr 18min

Dr. Zachary Knight: The Science of Hunger & Medications to Combat Obesity

Huberman Lab

In this episode, Dr. Zachary Knight, a professor of physiology at UCSF and HHMI investigator, provides a deep dive into the neurobiology of hunger, satiety, and thirst. He explains the brain's complex systems for regulating food intake and body weight, and how this knowledge is informing the development of new obesity medications.

0:00

-0:00

Key Takeaways

The brain has two main systems for regulating hunger and food intake - a short-term brainstem system that controls meal size, and a long-term hypothalamic system that tracks body fat levels and energy reserves
Leptin, a hormone released by fat cells, provides a key signal to the brain about energy stores and regulates hunger via the hypothalamus
Obesity is highly heritable, with genetics loading the gun and the environment pulling the trigger - the brain's hunger/satiety circuits are strongly influenced by both genetic and environmental factors
Highly processed foods with engineered palatability can override the brain's normal hunger/satiety signaling, leading to overconsumption and weight gain
GLP-1 agonist drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) work by potently activating GLP-1 receptors in the brainstem to powerfully suppress appetite and promote weight loss
The next generation of obesity drugs aim to combine GLP-1 agonism with other mechanisms (e.g. glucagon agonism) to further enhance weight loss while mitigating side effects

Introduction

In this episode, Dr. Zachary Knight, a professor of physiology at UCSF and HHMI investigator, provides a deep dive into the neurobiology of hunger, satiety, and thirst. He explains the brain's complex systems for regulating food intake and body weight, and how this knowledge is informing the development of new obesity medications.

Dr. Knight discusses the two main timescales of hunger regulation - a short-term brainstem system that controls meal size, and a long-term hypothalamic system that tracks body fat levels. He describes how the hormone leptin, released by fat cells, provides a key signal to the brain about energy reserves and regulates hunger.

The conversation then explores the genetic and environmental factors that contribute to the obesity epidemic, the role of processed foods in overriding normal hunger/satiety signaling, and the emerging class of GLP-1 agonist drugs that are revolutionizing obesity treatment.

Topics Discussed

Hunger Regulation: Short-Term vs. Long-Term Systems (7:07)

The brainstem contains a "short-term" system that controls meal size and termination, while the hypothalamus houses a "long-term" system that tracks body fat levels and energy reserves
Experiments with "decerebrate" rats (with the forebrain removed) showed the brainstem can still regulate meal size, but not long-term energy balance
The hypothalamus, particularly AgRP neurons, integrate signals like leptin to adjust hunger and food-seeking behavior based on energy stores

Leptin, Body Fat, and Hunger (11:28)

Leptin, a hormone secreted by fat cells, provides a key signal to the brain about energy reserves
Leptin inhibits the hunger-promoting AgRP neurons, reducing appetite when fat stores are high
Leptin resistance, where high leptin levels fail to adequately suppress hunger, is a major contributor to obesity

AgRP Neurons and Predictive Feeding Behavior (20:52)

AgRP neurons in the hypothalamus can predict how much an animal will eat even before the first bite, based on cues like smell and sight of food

This allows the brain to begin the process of satiety before the meal is consumed, optimizing energy balance

Anorexia nervosa may involve an exaggerated ability to estimate caloric content of foods

Genetics, Environment, and the Obesity Epidemic (39:54)

Obesity is highly heritable, with genetics accounting for ~80% of the variation in body weight

However, the rapid rise in obesity over the past 50 years is due to environmental factors, not genetics

Genetics "load the gun" by predisposing some individuals to obesity, while the modern environment "pulls the trigger"

Processed Foods and Palatability (46:05)

Highly processed foods with engineered palatability can override the brain's normal hunger/satiety signaling

Whole, minimally processed foods may be more satiating and better align with the brain's predictive feeding mechanisms

Learning to associate food flavors with their post-ingestive effects may be disrupted by processed food combinations

GLP-1 Agonists for Obesity Treatment (109:50)

GLP-1 agonist drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) powerfully suppress appetite by activating GLP-1 receptors in the brainstem

These drugs can produce 15-25% weight loss, approaching the results of bariatric surgery

Next-generation obesity drugs aim to combine GLP-1 agonism with other mechanisms (e.g. glucagon agonism) to further enhance weight loss

Conclusion

Dr. Knight provides a comprehensive overview of the neurobiology underlying hunger, satiety, and thirst regulation. He explains how the brain's complex, multilayered systems for controlling food intake and body weight are shaped by both genetic and environmental factors.

The discussion of processed foods, palatability, and the disruption of normal feeding behaviors offers important insights into the drivers of the obesity epidemic. Dr. Knight's clear explanations of the latest obesity medications, including GLP-1 agonists, and the future pipeline of even more potent drug combinations, suggest significant progress is being made in the fight against obesity.

Overall, this episode offers a deep dive into the neuroscience of hunger and satiety, translating cutting-edge research into practical knowledge that can help listeners better understand their relationship with food and make more informed choices about their diet and health.